Pharma
Celebrating our Centres - Leicester
This week we spoke to the team at the NIHR BioResource Centre Leicester about community engagement events at supermarkets to promote participation in research. In tandem, we also learn about Leicester’s very own NHS Trust Chief Executive, who has made a personal commitment to health res...
Happy 3rd Birthday to The Eating Disorders Genetics Initiative (EDGI) UK!
The Eating Disorders Genetics Initiative in the UK (EDGI UK) was launched 3 years ago, recruiting members of the public who have experienced any eating disorder. We spoke to the team to find out what's happened since the launch in 2020, achievements to date, who they've collaborated wit...
Sickle Cell Awareness Month 2023 – urgent plea for more donors of Black heritage
During this year’s Sickle Cell Awareness Month, the NHSBT urgently plea for 12,000 new Black donors, as demand from hospitals continues to grow. We discuss our contributions to blood disorder research, hailing the involvement from our volunteers and the importance of representation of d...
Strategies for combination therapy in oncology: Part one – Business as usual
This is the first in a three-part series examining the commercial dynamics surrounding combination therapy in oncology across the US and Europe. In this article, we discuss the challenges and opportunities within the current landscape and key issues impacting pricing and access for comb...
Strategies for combination therapy in oncology: Part two - Working with the “status quo”
This is the second article in a three-part series examining the commercial dynamics surrounding combination therapy in oncology across the US and Europe. In this article, we investigate strategies that manufacturers could consider to optimize pricing and access opportunities for their c...
Antimicrobial Resistance Policy Solutions
It is difficult to imagine someone who hasn’t called on antibiotics to help them through an infection or protect them during a surgery. Thanks to developments over the last 150 years, once life-threatening bacterial encounters have been relegated to minor inconveniences. Or have they? T...
Get to know the inflammatory bowel disease (IBD) team at the NIHR BioResource
Who are they, what a day looks like in the team and everything involved in making our Inflammatory Bowel Disease (IBD) team one of the core cogs in the workings of the NIHR BioResource! ...
Reflecting on our campaign to increase volunteer diversity
NIHR BioResource for Translational Research writes...As our 12-week campaign with Egality Health and eight community-based health advocacy organisations has come to a close, we’re reflecting on our successes and sharing some key learnings going forward. We also heard from some of our co...
Redundancy: A Golden-Ticket Opportunity (face to face or Virtual Event)
If you are in the Life Sciences, Pharma, Medical Devices or Health Tech industries, and whether you're currently facing potential redundancy, actively seeking a new opportunity, or have previously encountered redundancy and wish to share your experiences while extending a helping hand t...
Milner Therapeutics Institute to house world-class functional genomics laboratory, in new partnership with AstraZeneca and the Medical Research Council
The University of Cambridge announces a new partnership with AstraZeneca and the Medical Research Council (MRC) that will establish a new state-of-the-art functional genomics laboratory at the Milner Therapeutics Institute. ...